3 Askovich B, Hawkins JA, Sower CT, Minich LL, Tani LY, Stoddard G, Puchalski MD.Reoperative homograft right ventricular outflow tract reconstruction. 2 Bielefeld MR, Bishop DA, Campbell DN, Mitchell MB, Grover FL, Clarke DR.One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. 1 Kanter KR, Budde JM, Parks WJ, Tam VK, Sharma S, Williams WH, Fyfe DA.This procedure might reduce the number of operations needed over the total lifetime of patients with right ventricle–to–pulmonary artery conduits. This led to significant reduction in right ventricular systolic pressure (from 63☑8 to 45☑3 mm Hg, P25 mm Hg (log-rank test P=0.01) were associated with a higher risk of reoperations.Ĭonclusions- Percutaneous pulmonary valve implantation resulted in the ability to avoid surgical right ventricular outflow tract revision in the majority of cases. Methods and Results- Between September 2000 and February 2007, 155 patients with stenosis and/or regurgitation underwent percutaneous pulmonary valve implantation.
Customer Service and Ordering Informationīackground- Percutaneous pulmonary valve implantation was introduced in the year 2000 as a nonsurgical treatment for patients with right ventricular outflow tract dysfunction.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).However, a direct link between animal and human infection data could not be established in this study. Interestingly, the two laboratories with significantly higher seroprevalences are located in the regions with the largest goat populations as well as, for one laboratory, with the highest livestock density in Switzerland. Overall, seroprevalence in humans ranged between 1.7% and 3.5% from 2007 to 2011, and no temporal trends were observed. Annual human Q fever serology data were provided by five major Swiss laboratories. To our knowledge, this is the first study reporting C. burnetii quantities in a large number of small ruminant abortion samples. The quantification of C. burnetii in 97 ovine and caprine abortion samples by real-time PCR indicated shedding of >10 4 bacteria/g in 13.4% of all samples tested. The seroprevalence of C. burnetii in small ruminants was determined by commercial ELISA from a representative sample of 100 sheep flocks and 72 goat herds. Specific objectives of this cross-sectional study were to (i) estimate the seroprevalence of C. burnetii in sheep and goats, (ii) quantify the amount of bacteria shed during abortion and (iii) analyse temporal trends in human C. burnetii infections. In this study, we describe the current situation with respect to Coxiella (C.) burnetii infections in small ruminants and humans in Switzerland, as a basis for future epidemiological investigations and public health risk assessments. In Switzerland, the prevalence of Q fever in animals and humans has not been studied in recent years. The recent Q fever epidemic in the Netherlands raised concerns about the potential risk of outbreaks in other European countries.
0 kommentar(er)
